A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
367
Participants
Timeline
Start Date
June 30, 1931
Study Completion Date
July 31, 1994
Conditions
BronchitisBronchitis, Chronic
Interventions
DRUG
levofloxacin
All Listed Sponsors
collaborator
PriCara, Unit of Ortho-McNeil, Inc.
INDUSTRY
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00257140 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria | Biotech Hunter | Biotech Hunter